An international survey conducted by GSK and released for World Meningitis Day shows gaps in the knowledge parents feel they have about meningococcal disease and its potential consequences. Almost 7 in 10 parents said they don’t know enough about the different strains of meningococcal disease and the potential damage they can cause. On average, more than half of parents were either unsure or unaware that there are different types of bacteria that cause the disease.
The survey of 5,000 parents in Brazil, Canada, Germany, Italy and Portugal also shows that out of a list of 14 vaccine-preventable diseases, meningococcal disease is considered by many parents to pose a top three health risk to their children. Fifty-seven percent listed meningococcal disease among the top three health conditions they considered of greatest risk to children followed by Hepatitis B at 34 percent, pneumococcal disease at 27 percent, polio at 25 percent, tetanus at 20 percent and pertussis at 17 percent.
A sudden, potentially life-threatening illness, meningococcal disease kills on average one person every eight minutes worldwide. It typically manifests as bacterial meningitis – an infection of the membrane around the brain and spine; or bacteraemia – a bloodstream infection. The disease progresses rapidly and it can lead to death within 24-48 hours of the first symptoms; globally up to 1 in 10 of those infected may die and in the US about 10-15 percent of people will die.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7814851-gsk-survey-world-meningitis-day/
http://www.legalenglish.com/
Legal English is a unique language, with its own terms and expressions. Legal-Ease international specializes in Legal English for those that need to master it with absolute precision. Our seminars are a perfect way to learn this unique language. Contact us today at info@legalenglish.com www.legalenglish.com
http://legaljusticeadvocates.com
Aiding those in need, this explainer video for Legal Justice Advocates a team of lawyers with more than 40 years of combined experience to enforce clients' rights when it comes to disability discrimination and other forms of unequal treatment in the workplace and elsewhere. Legal Justice Advocates also handles consumer protection claims, bankruptcy and collections matters. The advocacy law firm can be reached at (202)803-4708 or go to their website and learn more at: http://legaljusticeadvocates.com
http://www.legalenglish.com/seminars/
Legal-Ease International trains Foreing lawyers, law students, translators, those needs Legal English around the World.
Register or contact us today for more information : www.legalenglish.com/seminars/
http://www.RenaultUSA.com The Scenic is probably the best example of why Renault has been the pioneer in the MPV (multi purpose vehicle) segment. Not only does this car offer a sense of sporty dynamism but it delivers a lot of cabin space and makes it the perfect vehicle for tall people. And of course, it offers multiple storage solutions and is perfect for those who travel with several pieces of luggage. Comparably sized vehicles in the USA are Nissan Rogue, Toyota Matrix.
Visit http://www.RenaultUSA.com to save up to 20%* on Car Rentals in Europe & France.
http://www.renaultusa.com
Join us on Facebook!: http://facebook.com/wheelsineurope
Follow us on Twitter: http://twitter.com/wheelsineurope
Learn the art of shadow puppetry from the Suso Master with more tutorials available at http://bit.ly/FacebookSuso
Ideal for students of the creative arts -- those looking to learn the early skills of hand and shadow puppetry -- or simply for those looking to have a bit of fun when it gets dark and there are only the shadows to play with.
Visit the SUSO Master on his Facebook site today to be entertained, maybe inspired, and for the chance to WIN exclusive prizes as you learn.
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today recognizes that more than one million people in the United States with drug-resistant epilepsy continue to be treated unsuccessfully with drugs, despite the proven effectiveness of non-drug treatment options. LivaNova’s VNS Therapy®, for example, is a medical device treatment specifically designed for people with drug-resistant epilepsy that is already used by more than 85,000 people around the world.
One in three people with epilepsy has the type that is not well controlled with drugs, called drug-resistant epilepsy. For those people, prescribing more medicine is usually not the most effective option. In fact, research shows that if you haven’t found seizure freedom after your first two drugs, there is a 95 percent chance that no drug or combination of drugs will result in seizure freedom.
“Despite what we know about drug-resistant epilepsy, the majority of people affected by this condition will continue to be prescribed additional medications instead of being evaluated for surgery or seen in a specialized epilepsy facility,” said Jason Richey, president of LivaNova’s U.S. Region and general manager of the Neuromodulation Business Franchise. “This treatment gap means over one million individuals in the U.S. with undertreated epilepsy remain at risk for dangerous side effects of continued seizures, including injury, depression, memory issues and death.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7966451-livanova-vns-therapy-epilepsy/
Announced today by VICHY Laboratoires, the VICHY EXPOSOME GRANT will promote and encourage research activity on the skin exposome. One research grant of 15 000 € will be awarded annually to a research project proposal in the field of exposome and skin.
What is exposome?
The human body is subjected to and responds to complex exposures throughout the lifespan, including exposures from the environment, diet, lifestyle. For this highly complex interaction, the term exposome was recently coined by Dr. Christopher Wild at the World Health Organization‘s International Agency for Research on Cancer.
The exposome analysis, therefore, complements the human genome by providing a comprehensive description of individuals’ lifelong environmental exposures. Exposome research aims to look at the holistic view of the human body’s exposures, how the body responds to those exposures, and their combined effects.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7751451-vichy-announces-exposome-grant/
The Bonnie J. Addario Lung Cancer Foundation invites you to join The Living Room, a lively and interactive online support group for those who are directly and indirectly affected by lung cancer. The April Living Room will feature a patient-focused program, titled “Sharing My Personal Journey.” There’s no guest speaker this month, just stories and experiences from patients and family who can offer hope to others.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56176-bjalcf-the-living-room-online-support-group-sharing-my-personal-journey
LONDON, 23 Jan., 2019 – Dell Technologies (NYSE:DELL) announces new additions to its portfolio of purpose-built technology designed to challenge, engage and inspire K-12 educators and students worldwide. This newest line of products, including an interactive monitor plus intelligently tough Latitude and Dell Chromebook devices and a new charging cart, helps educators integrate technology with new teaching and learning practices, while encouraging students to follow their own path of discovery.
“Recent Dell Technologies research on Generation Z – those born in the mid-1990s and later – confirms our belief that for students to be successful now and in the future, educators must empower them to drive their own success and support them with tools and resources that ignite students’ natural curiosities,” said Adam Garry, director of education strategy at Dell. “These new devices enable both educators and students to inquire, create and collaborate seamlessly, wherever learning takes place.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8356753-dell-technologies-bett-education/
Allergan, Inc. (NYSE: AGN), the makers of LATISSE® (bimatoprost ophthalmic solution) 0.03%, announced today the launch of the LATISSE® Wishes Challenge campaign. Inspired by the tradition of blowing on an eyelash to make wishes come true, lifestyle designer Kathy Ireland, professional ballroom dancer Chelsie Hightower and style guide Bobbie Thomas will each lead teams of LATISSE® users from across the country who are challenged to raise more than a quarter of a million dollars for the Make-A-Wish Foundation, a nonprofit organization dedicated to granting the wishes of children with life-threatening medical conditions. LATISSE® solution is the first and only prescription treatment approved by the U.S. Food and Drug Administration (FDA) to grow lashes longer, fuller and darker for those with inadequate or not enough lashes (eyelash hypotrichosis).
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/latisse/43354/
Lapponia Jewelry is undergoing a global renaissance. Today’s strong women want to express themselves with our beautiful designs. Lapponia Jewelry is inspired by the rugged nature of northern Finland. This close bond with the nature of the north is brought to life in our new brand experience, the Art of Expression video, and our overall marketing strategy, The Silent Language of Nature.
The Lapponia brand video combines stunning images of northern nature with another source of Finnish pride, the internationally renowned musical talent of the band Apocalyptica and their song Sacra. The video tells the story of Lapponia’s origins, presenting the artists’ source of inspiration for those who have never had the opportunity to experience the exotic beauty of northern Finland.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52795-lapponia
